Key facts
- Insight Surgery’s last known valuation is $12.5M (Feb 2025).
- It has raised $5.9M; the latest was Later Stage VC ($2.4M) in Feb 2025.
- Notable investors include Bigspace Investments, Fenwall Investments, Nodenza Venture Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Insight Surgery
- ·The full record, as it builds
Funding rounds
No funding rounds for Insight Surgery are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Insight Surgery
Provider of personalized surgery services intended for treatment in pediatrics, oncology, orthopedics, cyclophosphamide, methotrexate and cardiology. The company's service model focuses on delivering the technology at the point of care, putting engineering talent, three-dimensional (3D) software and printing hardware on-site in the hospital, enabling clinicians and surgeons to personalize their treatment strategies.
- Sector
- Healthcare
- HQ
- Liverpool, United Kingdom
- Founded
- 2013
- Employees
- 12
- Website
- insightsurgery.com/
- Ownership
- Privately Held (backing)
Insight Surgery doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Insight Surgery shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Insight Surgery in its N-PORT filings yet. We sweep new filings monthly.